Cybersecurity Firms Gain Three-Tier Access to Anthropic’s Claude Mythos and Latest ModelsOctober 7, 2026
How Professional Crypto Traders Use Multiple Exchanges to Arbitrage Execution, Not Just PriceJune 1, 2026
News U.S. Dollar Maintains Stability Ahead of Chair Warsh’s Inaugural Fed DecisionBy Ken CareyJune 17, 2026
Stock Michael Burry Declines SpaceX (SPCX) Short Position Despite Valuation ConcernsBy Ken CareyJune 17, 2026
Stock Microsoft (MSFT) Stock Slides After $3B Oracle Cloud Partnership Fails Due to Security IssuesBy Ken CareyJune 17, 2026
Stock Anthropic Eyes $1 Trillion Valuation in Upcoming IPO — Pre-IPO Investment Options AvailableBy Ken CareyJune 17, 2026
Crypto Dow Surges Past 52,000 Milestone as Iran Peace Agreement Lifts Market Sentiment Ahead of Fed MeetingBy Ken CareyJune 17, 2026
Stock Casino Industry Demands Congress Block Sports Betting from Crypto LegislationBy Ken CareyJune 17, 2026
Stock Forward Industries’ Solana Treasury Consolidation Push Meets Resistance from Three FirmsBy Ken CareyJune 17, 2026
Stock Ripple’s Strategic Investment in Flutterwave Brings RLUSD and XRP to African MarketsBy Ken CareyJune 17, 2026
Crypto Bitcoin Mining Industry Confronts $50B Capital Shortfall in AI Transformation, VanEck ReportsBy Ken CareyJune 17, 2026
Stock Coinbase (COIN) Unveils Massive Platform Overhaul with AI Trading Tools and Stock OptionsBy Ken CareyJune 17, 2026
Crypto June 2026 FOMC Meeting: Fed Holds Steady as Rate Hike Expectations SurgeBy Ken CareyJune 17, 2026
Stock UiPath (PATH) Stock: AI Automation Company Slips 2.7% as Maestro Case Debut Fails to Lift SharesBy Newton KitongaJune 17, 2026
Stock Super Micro Computer (SMCI) Stock: Drops 5% as Jane Street Takes 8.5% Stake Amid $7B AI Financing Dilution FearsBy Newton KitongaJune 17, 2026
Stock Nu Holdings (NU) Stock: Nubank Gains 2% Even After Citi Cuts Price Target to $13By Newton KitongaJune 17, 2026
Stock Pfizer (PFE) Stock: Rises as Investors Weigh New Cancer Drug Catalyst Against Patent RisksBy Newton KitongaJune 17, 2026
Stock Ondas (ONDS) Stock: Falls 3% Despite New Defense Systems and Growing Order BacklogBy Newton KitongaJune 17, 2026
Stock Moderna (MRNA) Stock Surges 9% Following Positive FDA Assessment of mRNA Flu VaccineBy Ken CareyJune 16, 2026
